Hmmmm….. interesting to see no comment so far on this excellent news from NYRADA.
Maybe the other good news from the Noxopharm team has overshadowed this latest news from NYA?
Two very exciting companies that are both now well on their way to having some early results to report. In the case of NYRADA….. that looks like being before the end of this calendar year.
It’s no coincidence that Prof Graham Kelly has been instrumental in both companies. In addition, the patent situation in both companies is also getting firmly established…. despite the doom and gloom dispersed by certain disgruntled parties.
Very well done to the NYRADA team. The two areas of involvement here are extremely important with potentially huge markets currently with an unmet need for much better drugs.
Its looking like the New Year will be an exciting new era for both. Brilliant news.
Apples
NYR Price at posting:
23.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)